Published in J Clin Psychopharmacol on October 01, 2001
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry (1995) 7.19
Computerizing guidelines to improve care and patient outcomes: the example of heart failure. J Am Med Inform Assoc (1996) 5.64
The Healthy Eating Index: design and applications. J Am Diet Assoc (1995) 5.19
Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull (1982) 3.63
Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol Biol (1997) 3.50
A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol (1999) 2.84
Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. Am J Ment Retard (2001) 2.23
Sex-related difference in amygdala activity during emotionally influenced memory storage. Neurobiol Learn Mem (2001) 2.15
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest (2001) 2.04
Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene (2000) 1.93
Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry (1996) 1.84
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry (1993) 1.80
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1989) 1.69
Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN study. Schizophr Bull (2009) 1.66
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology (2010) 1.63
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology (2006) 1.55
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci (1996) 1.50
Using electronic medical records to predict mortality in primary care patients with heart disease: prognostic power and pathophysiologic implications. J Gen Intern Med (1996) 1.47
Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli. Nat Struct Biol (1999) 1.46
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. Neuropsychopharmacology (1999) 1.45
Latex foam and staple fixation of skin grafts. Br J Oral Maxillofac Surg (1998) 1.39
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. J Clin Oncol (1994) 1.39
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A (2000) 1.37
Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry (1988) 1.36
Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. N Engl J Med (1984) 1.32
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex (1996) 1.31
Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry (1993) 1.30
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial. Can J Gastroenterol (2007) 1.28
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia. Mol Psychiatry (2001) 1.25
The Emergency Medical Treatment and Labor Act as a federal health care safety net program. Acad Emerg Med (2001) 1.24
Haloperidol concentrations elevated in Chinese patients. Psychiatry Res (1984) 1.14
Phosphine-induced oxidative damage in rats: attenuation by melatonin. Free Radic Biol Med (2000) 1.14
Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anticancer Agents (2003) 1.13
Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry (1992) 1.13
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology (Berl) (2001) 1.11
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
Screening for asthma in an inner-city elementary school in Minneapolis, Minnesota. J Sch Health (1999) 1.10
Uncoupling cognitive workload and prefrontal cortical physiology: a PET rCBF study. Neuroimage (1998) 1.09
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry (1992) 1.08
Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol (2001) 1.08
Human papillomavirus type 6-induced condylomata: an unusual complication of intertrigo. Br J Dermatol (1993) 1.08
The role of the principal sensory nucleus in central trigeminal pattern formation. Brain Res (1985) 1.07
A method for fixation of previously fresh-frozen human adult and fetal brains that preserves histological quality and immunoreactivity. J Neurosci Methods (1992) 1.07
NMDA receptor-mediated K+ efflux and neuronal apoptosis. Science (1999) 1.06
fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull (2008) 1.06
Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr (1990) 1.05
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut (2002) 1.05
Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. Health Technol Assess (2004) 1.04
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03
Seasonal affective disorder: prevalence varies with latitude and climate. Clin Neuropharmacol (1986) 1.03
Structured Interview for Assessing Perceptual Anomalies (SIAPA). Schizophr Bull (1999) 1.02
Relative sparing of emotionally influenced memory in Alzheimer's disease. Neuroreport (2000) 1.01
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia. Mol Psychiatry (2000) 0.98
Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry (1996) 0.98
S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurol Scand Suppl (1994) 0.98
S-adenosylmethionine treatment of depression: a controlled clinical trial. Am J Psychiatry (1988) 0.97
An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus. Am J Hum Genet (2000) 0.97
Cefotetan pharmacokinetics in volunteers with various degrees of renal function. Antimicrob Agents Chemother (1986) 0.95
Suicide prevention centers. Ecological study of effectiveness. J Nerv Ment Dis (1977) 0.95
Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res (1997) 0.95
Electrical stimulation of wrist and fingers for hemiplegic patients. Phys Ther (1979) 0.94
Stability of exploratory eye movements as a marker of schizophrenia--a WHO multi-center study. World Health Organization. Schizophr Res (2001) 0.94
Tardive dyskinesia--reversible and persistent. Arch Gen Psychiatry (1979) 0.93
Comedo naevus of the palm--a sweat duct naevus? Br J Dermatol (1979) 0.93
In situ hybridization studies of adenoviral infections of the lung and their relationship to follicular bronchiectasis. Am Rev Respir Dis (1989) 0.92
Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut (1995) 0.92
Twenty-nail dystrophy. Arch Dermatol (1979) 0.91
Phenylethylamine in paranoid chronic schizophrenia. Science (1979) 0.90
Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment. Clin Electroencephalogr (1998) 0.89
Lateralized attentional deficits in drug-free and medicated schizophrenic patients. Neuropsychologia (1997) 0.89
Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients. Biol Psychiatry (1980) 0.89
Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry (1998) 0.89
Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol (R Coll Radiol) (2008) 0.88
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology (1999) 0.88
Molecular characterization of Cyclospora-like organisms from baboons. J Infect Dis (1999) 0.87
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Pharmacogenomics J (2009) 0.87
Failure to isolate virus from CSF of schizophrenics. Lancet (1983) 0.87
Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry (2000) 0.87
Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia. Am J Psychiatry (1980) 0.87
Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J Hepatol (1996) 0.87
Limited eye movement patterns in chronic schizophrenic patients. Psychiatry Res (1989) 0.86
Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients. Psychiatry Res (2001) 0.86
Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health (1994) 0.86
Learning and forgetting in schizophrenia. J Abnorm Psychol (2000) 0.86
Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate. Br J Radiol (2008) 0.86
Platelet monoamine oxidase activity in schizophrenia: a review of the data. Am J Psychiatry (1979) 0.85
Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma. Brain Res (1977) 0.85
Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res (1996) 0.84
Electroencephalographic photic driving in patients with schizophrenia and depression. Biol Psychiatry (1997) 0.84
Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse (1990) 0.84
Topographic analysis of EEG photic driving in normal and schizophrenic subjects. Clin Electroencephalogr (1995) 0.84
New morphological and neuropathological findings in schizophrenia: a neurodevelopmental perspective. Clin Neurosci (1995) 0.84
Wheat gluten challenge in schizophrenic patients. Am J Psychiatry (1981) 0.83
Bipolar affective disorder partially cosegregates with a balanced t(9;11)(p24;q23.1) chromosomal translocation in a small pedigree. Am J Med Genet (1998) 0.83
Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.82
EEG resonant responses in schizophrenia: a photic driving study with improved harmonic resolution. Schizophr Res (2000) 0.82
Structure and functional relationships in human pur H. Adv Exp Med Biol (1998) 0.82